---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-25-000031"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2025-04-24T23:59:59+00:00"
generated_at: "2026-05-23T06:38:24.794135+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# West Pharma CFO Birkett to retire; Campbell named Chief Proprietary Segment Officer

## Summary
- CFO Bernard Birkett informed West of intention to retire; search for successor initiated; will remain until transition and then advisory role through Dec 31, 2025.
- Shane Campbell appointed SVP, Chief Proprietary Segment Officer effective May 5, 2025; previously at Carlisle Companies and DuPont.
- Campbell receives $600K base salary, 75% target bonus (2025 prorated), $1M LTI award (50% PSUs, 25% options, 25% RSUs), $400K sign-on RSU (4-year vest), and $100K sign-on cash bonus.
- Birkett joined West in June 2018 and served as CFO, also as CFO & COO from 2022 to April 2024.

## SEC filing metadata
- accession: 0000105770-25-000031
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2025-04-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577025000031/0000105770-25-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577025000031/wst-20250422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-25-000031
- JSON: https://secwatch.observer/filing/0000105770-25-000031.json
- Plain text: https://secwatch.observer/filing/0000105770-25-000031.txt

## Key facts
- Executive change
  Shane Campbell was appointed as Senior Vice President, Chief Proprietary Segment Officer at WEST PHARMACEUTICAL SERVICES INC.
  - Action: appointed
  - Role: Senior Vice President, Chief Proprietary Segment Officer
  source text: On April 24, 2025, the Company announced that it had appointed Shane Campbell to serve as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577025000031/0000105770-25-000031-index.htm
- Executive change
  Bernard Birkett departed as Senior Vice President & Chief Financial Officer at WEST PHARMACEUTICAL SERVICES INC.
  - Action: intends to retire
  - Role: Senior Vice President & Chief Financial Officer
  source text: On April 22, 2025, Mr. Bernard Birkett notified West Pharmaceutical Services, Inc. (the “Company”) of his intention to retire as Senior Vice President & Chief Financial Officer later this year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577025000031/0000105770-25-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.